Regional licensing and co-development.
We work with regional partners to extend access, accelerate registration and commercialise specialised products in territories where local expertise is decisive.
Three structured partnership models. Detailed materials shared under standard confidentiality terms.
Structured collaborations with retained value.
We work with partners across the development and commercialisation lifecycle — from co-development of early-stage programmes to regional licensing and distribution of commercialised products.
Each partnership is structured to preserve long-term value in core territories while accelerating access and commercial maturity in regions where local expertise is decisive.
Three structured models.
- 01
Regional licensing
In-licensing or out-licensing arrangements with specialist regional partners — for territories where local regulatory, clinical and access expertise is decisive.
- Territory-specific exclusivity
- Regulatory and reimbursement support
- Aligned commercial milestones
- 02
Co-development
Joint development arrangements for medicines, medical nutrition or medical foods — sharing scientific, regulatory and commercial inputs across organisations.
- Shared programme governance
- Defined contribution and reward structures
- Designed for early- and mid-stage assets
- 03
Distribution
Distribution partnerships for commercialised products, focused on specialist metabolic care channels and tertiary centres in target regions.
- Specialist channel coverage
- NHS, EU and partner-region routes
- Integrated patient-access support
Specialist capability in target territories.
- 01Specialist focus in metabolic, rare disease or related therapeutic areas
- 02Demonstrated regulatory and reimbursement capability in target territories
- 03Clinical network access at metabolic centres of excellence
- 04Aligned commitment to compliant, evidence-based commercialisation
A pipeline built for partner-led access.
Specific assets and stage information are available on the pipeline page. Detailed materials shared under standard confidentiality terms.
- 01Funded US development programmes
- 02Orphan-designated assets across multiple jurisdictions
- 03Differentiated medical nutrition and medical food formulations
- 04Retained long-term value in core territories
Considering a partnership? We'd like to hear from you.
For partnership, licensing or corporate enquiries, contact contact@metahealthcare.example.
We respond within two working days. Detailed materials shared under standard confidentiality terms.
